当前位置：药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目收费,不能显示细节,电话13136136841)
药品名称： 商品名称： 药品NDC： 报告期内： -格式:2020-5-3
NDC包装id： 市场分类： 活性成分： 持证企业：
 美国NDC复合药物数据库文件1279条(本栏目收费,不能显示细节,电话13136136841)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
Diphenhydramine 25mg added to NS
HUMAN COMPOUNDED DRUG
71285-7089
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
DIPHENHYDRAMINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
25 mg/50 mL
71285-7089-1
Heparin 4000units added to NS
HUMAN COMPOUNDED DRUG
71285-7022
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
HEPARIN SODIUM
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4000 U/1000 mL
71285-7022-1
Heparin 2500units added to NS
HUMAN COMPOUNDED DRUG
71285-8000
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
HEPARIN SODIUM
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2500 U/250 mL
71285-8000-1
Sodium Phosphate (4mEq/3mmol)/ml Compounded Solution
HUMAN COMPOUNDED DRUG
71285-8077
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
34.5 g/500 mL; 35.5 g/500 mL
71285-8077-1
Lidocaine 250mg added to NS
HUMAN COMPOUNDED DRUG
71285-8088
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
LIDOCAINE HYDROCHLORIDE ANHYDROUS
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
250 mg/250 mL
71285-8088-1
Induction 4 to1 High K (60mEq) 830ml Bag
HUMAN COMPOUNDED DRUG
72196-0100
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
SODIUM CHLORIDE; CITRIC ACID MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE; ANHYDROUS DEXTROSE; TROMETHAMINE; POTASSIUM CHLORIDE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; DEXTROSE MONOHYDRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
18.8 meq/830 mL; 1.635 g/830 mL; 13.15 g/830 mL; 23.2 g/830 mL; 7.2 g/830 mL; 60 meq/830 mL; 1.11 g/830 mL; 49.45 g/830 mL
72196-0100-1
Phenylephrine 10mg added to NS
HUMAN COMPOUNDED DRUG
71285-6058
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/250 mL
71285-6058-1
Potassium Phosphate 15mmol added to NS
HUMAN COMPOUNDED DRUG
71285-6060
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
POTASSIUM PHOSPHATE, DIBASIC
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
15 mmol/250 mL
71285-6060-1
Microplegia (MSA/MSG 0.92 Molar) 125ml Bag
HUMAN COMPOUNDED DRUG
71285-0001
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
ASPARTIC ACID; GLUTAMIC ACID
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
9.8 g/125 mL; 10.7 g/125 mL
71285-0001-1
Vancomycin 1.25gm added to NS
HUMAN COMPOUNDED DRUG
71285-6074
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
VANCOMYCIN HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1.25 g/250 mL
71285-6074-1
Vancomycin 1.5gm added to D5W
HUMAN COMPOUNDED DRUG
71285-6075
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
VANCOMYCIN HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1.5 g/250 mL
71285-6075-1
Vancomycin 1.5gm added to NS
HUMAN COMPOUNDED DRUG
71285-6076
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
VANCOMYCIN HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1.5 g/250 mL
71285-6076-1
Vancomycin 2gm added to NS
HUMAN COMPOUNDED DRUG
71285-6078
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
VANCOMYCIN HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 g/500 mL
71285-6078-1
Vancomycin 1.75gm added to NS
HUMAN COMPOUNDED DRUG
71285-7060
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
VANCOMYCIN HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1.75 g/500 mL
71285-7060-1
Lidocaine 500mg added to NS
HUMAN COMPOUNDED DRUG
71285-8089
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
LIDOCAINE HYDROCHLORIDE ANHYDROUS
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
500 mg/500 mL
71285-8089-1
Reperfusate 4 to1 NO K 238.75ml Bag
HUMAN COMPOUNDED DRUG
71285-0005
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
ASPARTIC ACID; TROMETHAMINE; GLUTAMIC ACID; DEXTROSE MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE; ANHYDROUS DEXTROSE; CITRIC ACID MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2.45392 g/238.75 mL; 2.0268 g/238.75 mL; 2.67928 g/238.75 mL; 6.09 g/238.75 mL; 14.8069 g/238.75 mL; 26.1232 g/238.75 mL; 1.84101 g/238.75 mL; 1.24986 g/238.75 mL
71285-0005-1
Maintenance 4 to1 Low K (20 mEq) 810ml Bag
HUMAN COMPOUNDED DRUG
72196-0103
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
TRISODIUM CITRATE DIHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; ANHYDROUS DEXTROSE; SODIUM CHLORIDE; TROMETHAMINE; POTASSIUM CHLORIDE; DEXTROSE MONOHYDRATE; CITRIC ACID MONOHYDRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
13.15 g/810 mL; 1.11 g/810 mL; 23.2 g/810 mL; 18.8 meq/810 mL; 7.2 g/810 mL; 20 meq/810 mL; 49.45 g/810 mL; 1.635 g/810 mL
72196-0103-1
Succinylcholine 20mg/ml
HUMAN COMPOUNDED DRUG
72196-6011
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
SUCCINYLCHOLINE CHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
72196-6011-2
Succinylcholine 20mg/ml
HUMAN COMPOUNDED DRUG
72196-6011
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
SUCCINYLCHOLINE CHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
72196-6011-1
Maintenance 4 to1 Low K (40 mEq) In Plasmalyte A, ph 7.4 with Tromethamine
HUMAN COMPOUNDED DRUG
71285-0112
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
SODIUM CHLORIDE; SODIUM GLUCONATE; MAGNESIUM CHLORIDE; SODIUM ACETATE; POTASSIUM CHLORIDE; MANNITOL; MAGNESIUM SULFATE HEPTAHYDRATE; TROMETHAMINE; DEXTROSE MONOHYDRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4.1028 g/1000 mL; 3.9156 g/1000 mL; .234 g/1000 mL; 2.8704 g/1000 mL; 3.2686 g/1000 mL; 7 g/1000 mL; 40.6 meq/1000 mL; 4.536 g/1000 mL; 12.53 g/1000 mL
71285-0112-1
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3